These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
573 related articles for article (PubMed ID: 26398882)
1. MicroRNAs involved with hepatocellular carcinoma (Review). Mao B; Wang G Oncol Rep; 2015 Dec; 34(6):2811-20. PubMed ID: 26398882 [TBL] [Abstract][Full Text] [Related]
2. Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma. Gailhouste L; Ochiya T Histol Histopathol; 2013 Apr; 28(4):437-51. PubMed ID: 23224781 [TBL] [Abstract][Full Text] [Related]
3. MicroRNAs as biomarkers for hepatocellular carcinoma diagnosis and prognosis. He S; Zhang DC; Wei C Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):426-34. PubMed ID: 25746139 [TBL] [Abstract][Full Text] [Related]
4. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma. Zhang YC; Xu Z; Zhang TF; Wang YL World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392 [TBL] [Abstract][Full Text] [Related]
5. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma. Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839 [TBL] [Abstract][Full Text] [Related]
6. miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients. Huang CY; Huang XP; Zhu JY; Chen ZG; Li XJ; Zhang XH; Huang S; He JB; Lian F; Zhao YN; Wu GB Oncol Rep; 2015 Jun; 33(6):2889-98. PubMed ID: 25962360 [TBL] [Abstract][Full Text] [Related]
7. The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment. D'Anzeo M; Faloppi L; Scartozzi M; Giampieri R; Bianconi M; Del Prete M; Silvestris N; Cascinu S Molecules; 2014 May; 19(5):6393-406. PubMed ID: 24853455 [TBL] [Abstract][Full Text] [Related]
8. Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison. Shen S; Lin Y; Yuan X; Shen L; Chen J; Chen L; Qin L; Shen B Sci Rep; 2016 Dec; 6():38311. PubMed ID: 27917899 [TBL] [Abstract][Full Text] [Related]
9. Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression. Chen E; Xu X; Liu R; Liu T Biomed Res Int; 2018; 2018():6784607. PubMed ID: 29951542 [TBL] [Abstract][Full Text] [Related]
10. Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma. Zhou Y; Liu F; Ma C; Cheng Q J Clin Lab Anal; 2022 Oct; 36(10):e24673. PubMed ID: 36036748 [TBL] [Abstract][Full Text] [Related]
11. The potential role of miRNAs 21 and 199-a in early diagnosis of hepatocellular carcinoma. Amr KS; Ezzat WM; Elhosary YA; Hegazy AE; Fahim HH; Kamel RR Gene; 2016 Jan; 575(1):66-70. PubMed ID: 26302751 [TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in the Occurrence and Development of Primary Hepatocellular Carcinoma. Xu J; Li J; Zheng TH; Bai L; Liu ZJ Adv Clin Exp Med; 2016; 25(5):971-975. PubMed ID: 28028963 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma. Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163 [TBL] [Abstract][Full Text] [Related]
14. MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma. Fiorino S; Bacchi-Reggiani ML; Visani M; Acquaviva G; Fornelli A; Masetti M; Tura A; Grizzi F; Zanello M; Mastrangelo L; Lombardi R; Di Tommaso L; Bondi A; Sabbatani S; Domanico A; Fabbri C; Leandri P; Pession A; Jovine E; de Biase D World J Gastroenterol; 2016 Apr; 22(15):3907-36. PubMed ID: 27099435 [TBL] [Abstract][Full Text] [Related]
15. HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma. Bronte F; Bronte G; Fanale D; Caruso S; Bronte E; Bavetta MG; Fiorentino E; Rolfo C; Bazan V; Di Marco V; Russo A Crit Rev Oncol Hematol; 2016 Jan; 97():312-21. PubMed ID: 26603462 [TBL] [Abstract][Full Text] [Related]
16. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma. Cai L; Cai X Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204 [TBL] [Abstract][Full Text] [Related]
17. Role of microRNAs in the main molecular pathways of hepatocellular carcinoma. Vasuri F; Visani M; Acquaviva G; Brand T; Fiorentino M; Pession A; Tallini G; D'Errico A; de Biase D World J Gastroenterol; 2018 Jul; 24(25):2647-2660. PubMed ID: 29991871 [TBL] [Abstract][Full Text] [Related]
18. Effects of sorafenib on lung metastasis in rats with hepatocellular carcinoma: the role of microRNAs. Shi Y; Huang A Tumour Biol; 2015 Nov; 36(11):8455-63. PubMed ID: 26026584 [TBL] [Abstract][Full Text] [Related]
19. New kids on the block: diagnostic and prognostic microRNAs in hepatocellular carcinoma. Ji J; Wang XW Cancer Biol Ther; 2009 Sep; 8(18):1686-93. PubMed ID: 19901517 [TBL] [Abstract][Full Text] [Related]
20. [microRNA: new diagnostic and therapeutic tools in liver disease?]. Gougelet A; Colnot S Med Sci (Paris); 2013 Oct; 29(10):861-7. PubMed ID: 24148124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]